close

March 13, 2025

Crown Bioscience Appoints John Gu as Chief Executive Officer

February 17, 2025

Crown Bioscience Completes Merger with Indivumed Services

February 11, 2025

Crown Bioscience Germany GmbH Achieves Continued CAP 15189:2022 Accreditation

December 11, 2024

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

December 10, 2024

Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation

December 12, 2024

Translating In Vitro and In Vivo Multi-Omics Oncology Data to Enhance Early Biomarker Discovery

October 30, 2024

Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biopsy Test

October 1, 2024

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

August 21, 2024

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

May 24, 2024

Crown Bioscience Enters Global Agreement with Shanghai Model Organisms Center

May 23, 2024

Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies

Contact Us
Biospecimen Request
Databases
CrownLink

US Tel: +1 858 622 2900

UK Tel: +44 870 242 2900

All Contact Information

Our Services
Our Science
About Us
Contact us

Blog

Orthotopic Models (13)

Preclinical Imaging of Non-Solid Tumors

6 minute read

Preclinical Imaging of Non-Solid Tumors

January 15, 2019

Preclinical Applications for Non-Invasive Imaging Technologies

5 minute read

Preclinical Applications for Non-Invasive Imaging Technologies

December 11, 2018

Exercise, Liver Cancer, and NAFLD Mortality

3 minute read

Exercise, Liver Cancer, and NAFLD Mortality

December 6, 2018

Where Do Organoids Fit in Preclinical Cancer Modeling?

6 minute read

Where Do Organoids Fit in Preclinical Cancer Modeling?

November 29, 2018

Are Cancer Stem Cells a Prime Target for Therapy?

10 minute read

Are Cancer Stem Cells a Prime Target for Therapy?

November 22, 2018

Prostate Cancer Patient-Derived Xenograft (PDX) Models

2 minute read

Prostate Cancer Patient-Derived Xenograft (PDX) Models

September 4, 2018

Why Are Prostate Cancer Preclinical Models Hard to Develop?

4 minute read

Why Are Prostate Cancer Preclinical Models Hard to Develop?

August 31, 2018

Assessing Combination Therapies in Syngeneic Tumor Models

3 minute read

Assessing Combination Therapies in Syngeneic Tumor Models

June 28, 2018

Understanding Cancer Progression and Metastasis

4 minute read

Understanding Cancer Progression and Metastasis

April 27, 2018

Preclinical Assessment of Osimertinib for NSCLC with EGFR Exon 20 Insertions

4 minute read

Preclinical Assessment of Osimertinib for NSCLC with EGFR Exon 20 Insertions

April 20, 2018

View Recent Posts View Older Posts

Search our Blog

Categories

About Us

Our Company
Our Purpose
Our Responsibility
Leadership
News & Events

Our Services

Platforms
Target Solutions
Technologies
Service Type

Resources

Blog
Preclinical Models
Publications
Factsheets
White Papers
Ebooks
Webinars

Platforms

OncoExpress™
XenoBase®
MuBase®
HuBase™
OrganoidBase™
CrownLink™

Talk To Us

+1 858 381 3547
Contact Us
Distributors
LinkedIn
X

© 2025 Crown Bioscience. All Rights Reserved.

Privacy Policy | Imprint | Terms of Service | Privacy Preferences

© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy

2025-03-03

2022-12-16